Deep-frying is a common cooking practice, and the safety of oxidised frying oil (OFO) ingested with fried food is a concern. During the deep-frying process, a series of reactions, including auto-oxidation, thermal oxidation, polymerisation, cyclisation and fission, occur in the frying oil(Reference Chang, Peterson and Ho1). Generally, OFO prepared using normal cooking practices as part of a nutritionally balanced diet is regarded as safe due to the induction of detoxifying cytochrome P450 enzymes and the limited absorption of toxic polymers produced during the deep-frying process(Reference Huang, Cheung and Lu2, Reference Gonzáles-Muñoz, Bastida and Sánchez-Muniz3). However, animal studies have revealed that some nutritional and metabolic effects related to OFO ingestion are noteworthy.
We(Reference Chao, Chao and Lin4–Reference Chao, Yang and Tseng6) and others(Reference Sulzle, Hirche and Eder7, Reference Eder, Suelzle and Skufca8) have shown that, in rats and mice, OFO ingestion can influence lipid metabolism through the activation of PPARα in the liver, leading to increased fatty acid catabolism. Paradoxically, impairment of glucose metabolism, i.e. glucose intolerance, is observed in OFO-fed rodents(Reference Chao, Huang and Liao9). When OFO-induced effects were compared with conjugated linoleic acid-induced lipodystrophic diabetes in mice, we found that, although both are characterised by body fat loss and glucose intolerance, OFO-mediated glucose intolerance is due to insufficiency of insulin secretion, compared with hyperinsulinaemia and insulin resistance caused by dietary conjugated linoleic acid(Reference Liao, Shaw and Chao10).
It has been reported that dietary OFO compromises vitamin E retention in many tissues, and that this can be attributed to a lower vitamin E intake and absorption and a faster catabolism/turnover(Reference Liu and Huang11–Reference Huang, Kang and Li13). Due to their relatively low expression of antioxidant enzymes, such as catalase and glutathione peroxidase (GPx), pancreatic β-cells are rather vulnerable to oxidative damage(Reference Lenzen, Drinkgern and Tiedge14, Reference Sigfrid, Cunningham and Beeharry15). Several lines of evidence have implicated reactive oxygen species (ROS) in the progression of β-cell dysfunction(Reference Kaneto, Fujii and Myint16–Reference Robertson20). Thus, although vitamin E content and free-radical scavenging systems in the pancreatic islets of OFO-fed mice have never been studied, it is conceivable that the reduced ability to secrete insulin caused by dietary OFO is associated with vitamin E deficiency and oxidative deterioration of pancreatic β-cells.
Pancreatic and duodenal homeobox factor-1 (PDX1), a transcription factor, plays a pivotal role in pancreatic β-cell differentiation and in insulin gene expression(Reference Ahlgren, Jonsson and Jonsson21). The DNA-binding activity of PDX1 is sensitive to glycation and the resulting oxidative stress(Reference Matsuoka, Kajimoto and Watada22). Since PDX1 DNA-binding activity under oxidative stress conditions is preserved or decreased, respectively, by the overexpression of dominant negative-c-Jun NH2-terminal kinase (JNK) or wild-type JNK(Reference Kaneto, Xu and Fujii23) and since dominant negative-JNK inhibits oxidative stress-induced PDX1 nucleocytoplasmic translocation(Reference Kawamori, Kajimoto and Kaneto24), it has been postulated that the JNK-mediated suppression of PDX1 DNA-binding activity accounts for some of the suppression of insulin gene transcription and of β-cell function related to oxidative stress(Reference Kaneto, Matsuoka and Nakatani25).
In the present study, we hypothesised that the OFO-induced impairment of glucose tolerance and insulin secretion is due to the oxidative damage of pancreatic islets, which is associated with vitamin E deficiency. We first examined the free-radical scavenging ability and ROS levels of islets from mice fed fresh soyabean oil or OFO and the involvement of JNK–PDX1 signalling in the reduction in insulin production in OFO-fed mice. Subsequently, we tested whether the adverse outcome in glucose metabolism associated with OFO ingestion could be prevented by vitamin E supplementation.
Materials and methods
Animals and diets
Male C57BL/6J mice (7-week-old) were purchased from the Laboratory Animal Center of the National Science Council, Taipei, Taiwan, ROC. After acclimatisation to a standard rodent chow diet for 1 week, the mice were divided into three groups to receive, for 8 weeks, a low-fat basal diet containing 4 g/100 g of fresh soyabean oil (LF group) or a high-fat diet containing 20 g/100 g of either fresh soyabean oil (HF group) or OFO (HO group). In a subsequent experiment, the HF, HO and HO+E groups were set up, with HF and HO as before and the HO+E group receiving the HO diet plus α-tocopherol acetate supplementation (500 IU(1·06 mmol all-rac-α-tocopherol acetate)/kg diet), again for 8 weeks. Since the OFO-containing diet resulted in a significant reduction in food intake, the LF and HF groups were isoenergically pair-fed with the HO (or HO+E) group. All animals were housed individually in stainless-steel wire cages in a room maintained at 23 ± 2°C, with a controlled 12 h light–12 h dark cycle and free access to tap water. The protocols for animal care and handling were approved by the Institutional Animal Care and Use Committee of the China Medical University.
The OFO was prepared by frying dough sheets in soyabean oil (President, Tainan, Taiwan, ROC) at 205 ± 5°C for four 6 h periods, as described previously(Reference Chao, Chao and Lin4–Reference Chao, Yang and Tseng6, Reference Chao, Huang and Liao9, Reference Liao, Shaw and Chao10). The extent of oxidation was evaluated by the acid value (1·413 v. 0·034 mg/g KOH for OFO and fresh soyabean oil, respectively) and the conjugated diene levels (4592 v. 618 OD233 units/g for OFO and fresh soyabean oil, respectively). The values were very similar to those obtained in our previous studies(Reference Chao, Chao and Lin4, Reference Chao, Huang and Liao9, Reference Liao, Shaw and Chao10). The compositions of the four test diets are shown in Table 1, the amounts of casein and the vitamin and mineral mixtures in the high-fat diets being adjusted to ensure that the four diets had an equivalent nutrient:energy ratio. The calculated vitamin E content (including dietary oil, vitamin mixture and supplement) of the four test diets is also shown in Table 1.
LF, low-fat basal diet containing 5 g/100 g of fresh soyabean oil; HF, high-fat diet containing 20 g/100 g of fresh soyabean oil; HO, high-fat diet containing 20 g/100 g of oxidised frying oil; HO+E, high-fat diet containing or oxidised frying oil with vitamin E supplementation.
* Oxidised frying oil was prepared by frying dough sheets in soyabean oil (President Company, Tainan, Taiwan, ROC) at 205 ± 5°C for 24 h.
† γ-Tocopherol levels in fresh soyabean oil and oxidised frying oil are 187 and 43 μg/g, respectively. α-Tocopherol levels in fresh soyabean oil and oxidised frying oil are 69 and 26 μg/g, respectively.
‡ Vitamin mixture contains 7·5 mg/g of all-rac-α-tocopherol acetate(Reference Reeves, Nielsen and Fahey35).
§ 1 IU = 1 mg all-rac-α-tocopherol acetate.
∥ Includes γ- and α-tocopherol in fresh soyabean oil or oxidised frying oil plus all-rac-α-tocopherol acetate in the AIN 93 vitamin mixture and the supplement. 1 mg of α-tocopherol = 1·49 IU; the biological function of γ-tocopherol is only 0·1 of that of α-tocopherol(Reference Kappus and Diplock33).
Oral glucose tolerance test
For the oral glucose tolerance test, the mice were fasted overnight, then tail blood was collected before (0 min) and at 30, 60, 90 and 120 min after oral administration of a 2·5 m-glucose solution (1·5 g/kg body weight), and whole blood glucose was measured using a MediSense Optium glucometer (Abbott Laboratories, Worcester, MA, USA).
Preparation of mouse pancreatic islets
Islets were isolated by modification of the methods of Lacy & Kostianovsky(Reference Lacy and Kostianovsky26) and Gotoh et al. (Reference Gotoh, Maki and Satomi27). In brief, fasting mice were anaesthetised under diethyl ether and the abdomen was opened, and the common bile duct was tied at its entrance to the duodenum. The duct was then cannulated, and 2 ml of a collagenase solution (1·2 mg/ml) was injected to distend the pancreas, which was then immediately dissected, put into a plastic tube and incubated at 37°C for 15–25 min. After dispersing the digested materials, the reaction was stopped by the addition of 15 ml of cold Hanks' balanced salt solution (HBSS), the tube was centrifuged at 125 g for 3 min, and the pellet was washed gently three times with cold HBSS. The pellet was then suspended in Roswell Park Memorial Institute (RPMI)-1640 medium (Sigma-Aldrich, St Louis, MO, USA) and passed through a 500 μm mesh filter to remove large undigested particles. Then, the filtrate was overlaid on top of 5 ml of Histopaque and centrifuged at 200 g for 25 min. The islets at the interface were collected and washed three times with cold HBSS.
Measurement of glucose-stimulated insulin secretion
Freshly isolated islets were incubated in RPMI-1640 medium containing 2·5 mm-glucose in 5 % CO2 at 37°C for 24 h to recover. To measure glucose-stimulated insulin secretion (GSIS), three sets of thirty islets from the same mouse were incubated for 30 min with 300 μl of RPMI-1640 medium (number of mice tested in each group, 5). Since GSIS might be affected by islet size, islets of a similar size were picked under a microscope for the present study. After challenging with high glucose (20 mm) for 10 min, the culture supernatants were collected to measure released insulin using an ELISA (Linco, St Charles, MO, USA).
Biochemical analysis
α-Tocopherol concentration in the serum and liver and pancreas homogenates was analysed by HPLC as described previously(Reference Liu and Huang11, Reference Liu and Huang12). Thiobarbituric acid-reactive substance levels in the liver homogenate were measured using the method of Oteiza et al. (Reference Oteiza, Olin and Fraga28). To measure oxidative damage to the islets, total antioxidant ability, GPx activity and lipid hydroperoxide (LPO) levels in the isolated islets were measured using commercial kits (Cayman, Ann Arbor, MI, USA), according to the manufacturer's protocols.
The islet mitochondrial membrane potential (ΔΨm) was determined using a commercial kit, which uses 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolocarbocyanine iodide (JC-1) as a mitochondrial membrane sensor (Sigma-Aldrich). JC-1 undergoes potential-dependent accumulation in mitochondria and shows a fluorescence emission shift from green (approximately 525 nm) to red (approximately 595 nm)(Reference Cossarizza, Baccarani-Contri and Kalashnikova29), which can be observed under a fluorescence microscope. ROS levels in islets were measured using 2′,7′-dichlorodihydrofluorescein diacetate (Sigma-Aldrich)(Reference Xie, Kometiani and Liu30). Briefly, three sets of thirty islets freshly prepared from each mouse (n 5) were incubated with 800 μl of HBSS (5 mm-glucose) containing 10 μm-2′,7′-dichlorodihydrofluorescein diacetate for 30 min at 37°C. Then, after three washes with HBSS, the islets were lysed by the addition of 200 μl of deionised water and the supernatant was collected to quantify the fluorescence (λex/λem = 485/528 nm).
Protein electrophoresis and immunoblotting
The islets were homogenised in radioimmunoprecipitation assay buffer (50 mm-Tris buffer, pH 7·4, containing 150 mm-NaCl, 1 mm-EDTA, 1 % NP-40, 0·25 % sodium deoxycholate, 0·1 % SDS, 1 % protease inhibitor cocktail and 1 % phosphatase inhibitor cocktail (both from Sigma-Aldrich)). Then, the samples (40 μg of protein) were subjected to electrophoresis on 10 % SDS gels, transferred to a polyvinylidene fluoride-plus transfer membrane (NEN Life Science, Boston, MA, USA) and immunoblotted. Primary antibodies used were rabbit antibodies against human insulin (Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA), human phosphor-JNK1+JNK2 (Thr183 and Tyr185) (Cell Signaling, Danvers, MA, USA), human total JNK (Abcam, Cambridge, MA, USA), or mouse PDX1 (Chemicon, Billerica, MA, USA) or mouse antibody against Xenopus β-actin (Novus, Littleton, CO, USA). Horseradish peroxidase-labelled donkey anti-rabbit IgG or horseradish peroxidase-labelled goat anti-mouse IgG antibodies (Amersham International, Amersham, UK) were used as the secondary antibody. Bound antibodies were detected using an enhanced chemiluminescence Western blotting kit (Amersham International), and the images were quantified by densitometric analysis using a MultiImage Light Cabinet (Alpha Innotech Corporation, San Leandro, CA, USA).
Immunohistochemistry
Islet morphology was studied by histological examination. Pancreas was fixed with 4 % paraformaldehyde, dehydrated through a graded ethanol series, embedded in paraffin and cut into 2 μm sections. Paraffin blocks were rehydrated with xylene, followed by decreasing concentrations of ethanol, permeabilised with 0·5 % Triton X-100 in PBS for 5 min and blocked with 5 % goat serum in PBS for 1 h at room temperature. Guinea-pig antibody against human insulin (Abcam) and Alexa Fluor 488-labelled goat anti-guinea pig IgG antibodies (Invitrogen, Carlsbad, CA, USA) were used as the primary and secondary antibodies, respectively. The β-cell area was measured by acquiring images at 200 × with a fluoromicroscope equipped with a SPOT RT color-2000 digital camera (Diagnostic Instruments, Sterling Heights, MI, USA). Islet size was quantified in the area containing insulin-positive cells using SPOT Advanced software (Diagnostic Instruments).
Statistical analysis
Data are expressed as means with their standard errors for the eight mice per group (for GSIS and ROS, n 5). The significance of differences between groups was analysed statistically by one-way ANOVA and Duncan's multiple range tests. Data were transformed to log values for the statistical analysis if the variances were not homogeneous. The general linear model of the Statistical Analysis Systems statistical software package (SAS Institute, Cary, NC, USA) was used for both statistical analyses, and differences were considered significant at P < 0·05.
Results
Since the animals were pair-fed isoenergically, there was no difference in energy intake between the LF, HF and HO groups (Table 2) or between the HF, HO and HO+E groups (data not shown). Dietary OFO-induced impairment of glucose tolerance and insulin secretion is shown in Table 2. Compared with the LF and HF groups, the HO group showed the highest area under the curve in the oral glucose tolerance test and the lowest fasting serum insulin levels and GSIS.
TBARS, thiobarbituric acid-reactive substances; AUC, area under the curve; OGTT, oral glucose tolerance test; GSIS, glucose-stimulated insulin secretion.
a,b Mean values within a row with unlike superscript letters were significantly different (P < 0·05; one-way ANOVA and Duncan's multiple range test).
* AUC for blood glucose over 2 h in the OGTT (1·5 g/kg of body weight).
† GSIS was measured by incubating isolated islets with 20 mm-glucose for 10 min. The insulin released per islet is expressed as a percentage of that in the LF group, assigned as 100 %.
In accordance with previous studies on dietary OFO-compromised vitamin E status in tissues, resulting in a higher oxidative stress(Reference Liao, Shaw and Chao10–Reference Liu and Huang12), liver α-tocopherol in the HO group was significantly lower, and thiobarbituric acid-reactive substances levels were significantly higher, than in the other two groups, with no difference between the LF and HF groups (Table 2). Since OFO-mediated vitamin E depletion and peroxidative stress in pancreatic islets have never been studied, total antioxidant ability, GPx activity and LPO content in islets were measured. As shown in Fig. 1(A), the HO group, but not the HF group, had a significantly lower total antioxidant ability than the LF group (P < 0·05). When the HF and HO groups were compared, dietary OFO resulted in a significant reduction in GPx activity (Fig. 1(B)) and an increase in LPO content (Fig. 1(C)) in islets.
Next, we examined whether ROS levels increased in islets from the HO group and decreased the mitochondrial membrane potential, which is critical for insulin secretion(Reference Maechler, Jornot and Wollheim18). As shown in Fig. 2(A), intracellular ROS production in islets was significantly higher in the HO group than in the HF and LF groups. Fig. 2(B) shows the fluorescence shift of the mitochondrial membrane potential sensor and that the HO-group islets fluoresced green, while the HF-group islets showed both yellow and green fluorescence, implying a lower mitochondrial membrane potential in the HO-group islets. This is in accordance with the notion that the mitochondrial membrane potential (ΔΨm) is positively correlated with GSIS(Reference Heart, Corkey and Wikstrom31).
Since oxidative stress might down-regulate insulin expression through JNK activation and reduce levels of PDX1, which is needed for insulin gene transcription(Reference Kaneto, Xu and Fujii23–Reference Kaneto, Matsuoka and Nakatani25, Reference Kawamori, Kaneto and Nakatani32), islet proteins were subjected to electrophoresis and immunoblotting. Fig. 3 shows a significant increase in phospho-JNK levels and a significant decrease in PDX1 and insulin levels in the HO-group islets compared with islets from the other two groups (P < 0·05; HO group v. LF and HF groups).
Finally, we tested whether vitamin E supplementation could prevent the adverse outcomes seen in the HO group. A depletion of tissue vitamin E caused by dietary OFO was seen in the serum, liver and pancreas (Table 3). Large-dose vitamin E supplementation resulted in a vitamin E status in the liver and serum in HO+E group even higher than that in the HF group and increased levels in the pancreas compared with those seen in the HF group. Since the vitamin E concentrations vary with the lipid content(Reference Kappus and Diplock33), vitamin E levels in the liver and serum were corrected by the TAG content, but the results were the same (pancreas vitamin E levels could not be corrected by the TAG content due to the limited sample size). In the HO+E group, the levels of glucose tolerance, serum insulin and GSIS were similar to those in the HF group (Table 3).
AUC, area under the curve; OGTT, oral glucose tolerance test; GSIS, glucose-stimulated insulin secretion. a,b,c Mean values within a row with unlike superscript letters were significantly different (P < 0·05; one-way ANOVA and Duncan's multiple range test).
* AUC for blood glucose over 2 h in the oral glucose (1·5 g/kg of body weight) tolerance test (OGTT).
† The GSIS was measured by incubating isolated islets with 20 mm-glucose for 10 min. The insulin released per islet is expressed as a percentage of that in the LF group, assigned as 100 %.
During the GSIS analysis, we observed that the islets in the HO group were smaller and fragile and therefore compared islet morphology in the HF, HO and HO+E groups. Immunostaining for insulin (Fig. 4(A)) showed that the pancreatic islets in the HO group were smaller than those in the HF and HO+E groups and irregular in shape, in contrast to the spherical shape seen in the other two groups. Islet size (sectional area) in the HO group was only one-third of that in the HF group and, although vitamin E supplementation significantly attenuated the reduction in islet size caused by OFO, islet size in the HO+E group was still significantly smaller than that in the HF group (Fig. 4(B)).
Discussion
In contrast to the effect of an OFO-containing diet on lipid metabolism(Reference Chao, Chao and Lin4–Reference Eder, Suelzle and Skufca8), the effect of such a diet on glucose metabolism has received little attention. We were the first to report that, in rodents, a high-OFO diet is less adipogenic than a diet containing the same amount of fresh soyabean oil, but causes glucose intolerance(Reference Chao, Huang and Liao9). In a further study, we showed that the glucose intolerance elicited by dietary OFO is due to the impairment of insulin secretion, rather than peripheral insulin resistance(Reference Liao, Shaw and Chao10). In the present study, we demonstrated that dietary OFO ingestion, by depleting tissue vitamin E, causes oxidative stress in pancreatic islets, thus compromising insulin secretion by lowering the mitochondrial membrane potential and decreasing insulin synthesis through the activation of JNK coupled with an inactivated PDX1 pathway. When the OFO-induced decrease in tissue vitamin E was prevented by large-dose oral vitamin E supplementation, the OFO-mediated impairment of glucose tolerance and insulin secretion was prevented, and the function was maintained at levels equivalent to those in the HF group. In addition, the OFO-mediated reduction in β-cell mass was also attenuated.
One possible concern about the present study could be that, since fresh soyabean oil contains abundant amounts of vitamin E (especially in the γ-tocopherol form), which is destroyed during the deep-frying process(Reference Liu and Huang11), there might be differences in the vitamin E content of the three experimental diets (LF, HF and HO), making the interpretation of the results difficult. However, as shown in Table 1, the vitamin E content of the HF diet was actually slightly higher than those in the other two diets, and the HO diet contained the same amount of vitamin E as the LF diet (all meeting the recommended vitamin E requirements in AIN-93, i.e. 75 IU(0·16 mmol all-rac-α-tocopherol acetate)/kg diet). However, only the HO group suffered oxidative stress, as indicated by the liver vitamin E and thiobarbituric acid-reactive substance levels, and the HO group was the only group with impaired glucose tolerance. Based on the lack of any difference in tissue vitamin E content and glucose tolerance between the LF and HF groups, the HF group was assumed to be normal, and some comparisons were therefore made directly between the HF and HO groups (Table 3).
Dietary OFO-induced oxidative stress and OFO-compromised tissue vitamin E retention have been extensively studied(Reference Liu and Huang11–Reference Huang, Kang and Li13, Reference Izaki, Yoshikawa and Uchiyama34). In the present study, for oral supplementation, we used a level of all-rac-α-tocopherol acetate (i.e. 500 IU/kg diet) 6·6-fold higher than the AIN-93 recommendation level(Reference Reeves, Nielsen and Fahey35). This dose has been shown to successfully prevent the reduction in α-tocopherol and the increase in thiobarbituric acid-reactive substances in the tissues of rats fed the OFO diet(Reference Liu and Huang11). Pancreas α-tocopherol levels in OFO-fed animals had not previously been tested, and the results showed that this dose was also sufficient to maintain α-tocopherol levels in the pancreas, but not as efficiently as in the liver or serum (Table 3). This might be attributed to a lower uptake or increased consumption of α-tocopherol in pancreatic cells.
Similar to the present findings, Tsujinaka et al. (Reference Tsujinaka, Nakamura and Maegawa36) reported that hydroperoxide from a dietary origin contributes to islet dysfunction. Using an air-dried vitamin E-stripped chow diet (containing autoxidative lipids), they showed that a diet high in LPO results in an increased LPO content in tissues and glucose intolerance in Sprague–Dawley rats(Reference Tsujinaka, Nakamura and Maegawa36). Glucose intolerance was associated with the development of both insulin resistance and an inability to secrete insulin. In response to oxidative stress, activation of a NF-κB signalling pathway in islet cells from LPO-fed rats was observed. In our OFO model, impairment of insulin secretion, but not of insulin sensitivity, has been observed(Reference Chao, Huang and Liao9, Reference Liao, Shaw and Chao10). One difference between the study of Tsujinaka and the present study was that the OFO used in the present study was much lower in LPO than the autoxidative lipids used by Tsujinaka(Reference Chao, Chao and Lin4, Reference Liu and Huang11, Reference Tsujinaka, Nakamura and Maegawa36). During the deep-frying process, LPO, the primary oxidative product, is volatilised or decomposed into secondary products at this high temperature(Reference Chang, Peterson and Ho1). Thus, the accumulation of LPO in the tissues of OFO-fed mice in the present study was attributed to endogenous production due to a lower free-radical scavenging ability. However, a compromised vitamin E status was seen in both studies and might be the cause of deterioration in glucose metabolism.
The present study is the first to evaluate the free-radical scavenging ability of islets in OFO-fed mice. In parallel with vitamin E depletion, the reduced total antioxidant ability and GPx activity and the higher LPO and ROS content in the HO group indicate that the OFO-exposed islets were subjected to greater oxidative stress. ROS have been shown to be involved in pancreatic β-cell dysfunction and apoptosis in a rodent model of type 1 diabetes(Reference Kaneto, Fujii and Myint16–Reference Sakai, Matsumoto and Nishikawa19) and in the failure of the first phase of GSIS in type 2 diabetes(Reference Robertson20). Histological analyses of pancreatic islets in the HO group showed that islet size was markedly reduced compared with its high-fat counterpart (i.e. HF group) and was partially prevented by vitamin E supplementation. The reduction in β-cell mass might be due to the increased apoptosis or decreased proliferation of β-cells. ROS-mediated β-cell death has been shown to be regulated by interactions between stress-activated protein kinases through phosphorylation/dephosphorylation cascades, which result in sustained JNK activation, thus leading to cell apoptosis(Reference Hou, Torii and Saito37). Although apoptosis of β-cells was not examined in the present study, increased ROS production and JNK activation were seen in the islets from the HO group.
The decreased ΔΨm and GSIS in the islets of OFO-fed mice indicate that the mitochondria were also subjected to ROS-induced damage, which interrupts the signal transduction normally coupling glucose metabolism to insulin secretion. The expression and function of uncoupling protein 2 has been shown to be increased by ROS superoxide(Reference Echtay, Roussel and St-Pierre38). In addition, induction of uncoupling protein 2 mRNA in β-cells is stimulated by fatty acid β-oxidation(Reference Li, Skorpen and Egeberg39). Although OFO-mediated PPARα activation in pancreatic islets has never been studied, it is possible that dietary OFO increases fatty acid β-oxidation not only in the liver(Reference Chao, Chao and Lin4, Reference Sulzle, Hirche and Eder7), but also in other tissues, thus increasing uncoupling protein 2 expression in islets. Uncoupling protein 2 impairs GSIS by causing mitochondrial proton leakage and a consequent negative effect on ATP production(Reference Krauss, Zhang and Scorrano40).
Although c-JNK, p38 MAPK and protein kinase C have been shown to be activated in islets subjected to oxidative stress, only JNK activation has been recognised as being responsible for the ROS-mediated down-regulation of insulin gene expression(Reference Kaneto, Xu and Fujii23, Reference Kawamori, Kajimoto and Kaneto24). JNK activation suppresses insulin expression by decreasing PDX1 levels and functions, such as DNA-binding activity or nuclear translocation(Reference Kaneto, Xu and Fujii23, Reference Kawamori, Kajimoto and Kaneto24). In accordance with this notion, increased JNK phosphorylation, accompanied by reduced levels of PDX1 and insulin, in the islets of OFO-fed mice was seen in the present study. The down-regulation of insulin might be attributed to lower transcription factor PDX1 levels and activity. Several mechanisms have been postulated to explain the decrease in PDX1 levels due to oxidative stress. ROS can suppress PDX1 transcription by inducing nuclear localisation of forkhead box O1 (an inhibitor of PDX1 transcription)(Reference Kawamori, Kaneto and Nakatani32). Moreover, oxidative stress might affect PDX1 gene expression through acetylation of histones H3 and H4 bound to the PDX1 promoter(Reference Wang, Vatamaniuk and Wang41). It has also been reported that oxidative stress decreases PDX1 protein stability through phosphorylation by a glycogen synthase kinase 3-dependent pathway, leading to its degradation in the proteosome(Reference Boucher, Selander and Carlsson42).
Currently, it is not known whether inflammation is involved in OFO-induced islet dysfunction. We have measured TNF-α protein levels in islets from fresh soyabean oil- or OFO-fed mice, but found no difference (data not shown). Since significantly higher levels of PGE2 metabolites have been observed in the plasma and urine of OFO-fed rats(Reference Huang43) and increased PGE2 expression in islets has been shown to result in the destruction of pancreatic islets(Reference Oshima, Taketo and Oshima44). The effect of oxidative stress, inflammation and apoptosis on β-cells and OFO-induced islet dysfunction awaits further study.
In conclusion, the present study shows that a high level of ingestion of dietary OFO without additional vitamin E supplementation impairs glucose metabolism by causing oxidative damage to pancreatic islets. Increased ROS levels and a decreased free-radical scavenging ability were observed in islets of OFO-fed mice. The reduction in insulin secretion in the islets of OFO-fed mice was associated with a lower mitochondrial membrane potential, and the reduced insulin synthesis was associated with JNK activation coupled to a reduction in PDX1 levels. OFO-mediated islet dysfunction is caused by vitamin E deficiency, which is secondary to OFO ingestion, since supplementation with vitamin E can prevent these adverse effects on glucose metabolism.
Acknowledgements
The present study was financially supported by grants from the National Science Council (NSC98-2320-B-039-039-MY3), Taiwan. We thank J. H. Juang for the technical assistance in islet isolation. The authors declare that there are no conflicts of interest. P.-M. C. designed the study; Y.-F. C., H.-M. S., M.-F. Y., C.-Y. H., and C.-H. H. conducted the study; Y.-F. C. and H.-M. S. analysed the data; P.-M. C. wrote the manuscript and had primary responsibility for the final content. All authors read and approved the final manuscript.